[Qualitative assessment of labile blood product prescription in Le Havre Hospital].
This retrospective study assessed the conformity of prescriptions of labile blood products as well as the respect of legal requirements and recommendations concerning red blood cells specifications. This study was carried out in two phases one year apart, so as to be able to compare between them. It consisted in an analysis of the administrative and medical information present on the prescription forms and of the discrepancies between the prescribed product and that which was dispensed. Quality of prescriptions was overall better, but some points needed further improvement. The data moreover showed that some prescriptions of phenotyped and cross-matched red blood cells were incomplete. This did not improve over time. Out of 1000 prescriptions for red blood cells, 216 were altered by the transfusion service dispensing unit. A closer look at these changes showed that 49% were justified by statutory requirements or by local protocols. The discrepancies observed between the prescribed product and that which was dispensed were partly due to a poor understanding by the prescribers of statutory requirements. However they are mostly related to particular circumstances, such as emergencies. Furthermore, the prescribers expected the transfusion center to adapt the product in terms of the clinical context.
Damais-Cepitelli
A
A
Unité d'hémovigilance, groupe hospitalier du Havre, BP 24, 76083 Le Havre, France. adamais@ch-haire.fr
Martin
P
P
Devos
A M
AM
Le Gueult
L C
LC
D004282:Documentation; D017707:Erythrocyte Transfusion / Q000331:legislation & jurisprudence / Q000592:standards* / Q000706:statistics & numerical data; D005602:France; D006801:Humans; D055656:Prescriptions / Q000592:standards* / Q000706:statistics & numerical data; D011785:Quality Assurance, Health Care; D011786:Quality Control; D012189:Retrospective Studies